Funded Startups in Trondheim
Eleven recent rounds are listed for Trondheim, spanning 2021-10-14 (OptoScale) to 2024-11-18 (Biosergen AS).
Eleven recent rounds are listed for Trondheim, spanning 2021-10-14 (OptoScale) to 2024-11-18 (Biosergen AS). The largest disclosed round is Maritime Robotics’ $12M on 2024-09-12, with several other disclosed rounds clustering between $3M and $5M (Versiro $3M on 2024-07-03; Seaweed Solutions $5M on 2023-01-16; Nomono $4M on 2022-09-14; OptoScale $5M on 2021-10-14). The smallest disclosed amount is Stready’s $100K on 2022-03-21, which stands out as a clear funding-size outlier relative to the rest of the disclosed figures.
Timing is also concentrated: four rounds fall within a ~6-week window in July 2024 (Leasi $1M on 2024-07-01; Versiro $3M on 2024-07-03), plus adjacent entries in 2024 (Biosergen AS $4M on 2024-11-18; Maritime Robotics $12M on 2024-09-12; CardioMech $13M on 2024-01-02). Sector-wise, Biotechnology is the only category appearing 3+ times (Biosergen AS; CardioMech; plus CardioMech’s separate biotech listing), while “Series Unknown” is the dominant round classification among the disclosed amounts (5 of 11 rows).
Most recent rounds
11 shownRelated listings
Frequently asked
What are the biggest and smallest disclosed rounds in this Trondheim list, and how extreme are they?
Maritime Robotics’ $12M on 2024-09-12 is the largest disclosed amount, while Stready’s $100K on 2022-03-21 is the smallest; the Stready figure is dramatically below the rest of the disclosed rounds, which mostly sit in the $1M–$5M range.
Do the Trondheim rounds cluster tightly by date, or are they spread out evenly?
They’re concentrated toward 2023–2024: Maritime Robotics ($12M) on 2024-09-12, Biosergen AS ($4M) on 2024-11-18, and CardioMech ($13M) on 2024-01-02 bookend a dense period that includes multiple 2023 rounds such as Zeabuz ($2M) on 2023-02-20 and Seaweed Solutions ($5M) on 2023-01-16.
Is any sector over-represented compared with the others across these 11 rows?
Biotechnology is the only sector that appears in 3+ entries (Biosergen AS on 2024-11-18; CardioMech on 2024-01-02; and Zeabuz is categorized as Science and Engineering rather than Biotechnology, so biotechnology concentration is limited to those biotech-labeled rows). All other sectors in the list appear once or twice at most (e.g., Agriculture and Farming: Seaweed Solutions 2023-01-16 $5M; OptoScale 2021-10-14 $5M).
Which funding-stage labels dominate here, and where do you see the biggest stage gaps?
“Series Unknown” appears in 5 of 11 rows (e.g., Maritime Robotics $12M on 2024-09-12; CardioMech $13M on 2024-01-02; Biosergen AS $4M on 2024-11-18). The smallest disclosed round comes from a non-equity label (Stready, Non-equity Assistance, $100K on 2022-03-21), creating a noticeable gap versus equity-typed or higher-disclosed amounts like Seed rounds (e.g., Seaweed Solutions $5M on 2023-01-16).
Which recent entries (roughly latest quarter) would be most relevant for outreach based on recency?
Within the latest 90 days relative to the most recent date shown (2024-11-18), the list contains Biosergen AS ($4M) on 2024-11-18 and Maritime Robotics ($12M) on 2024-09-12. The next most recent disclosed rounds are CardioMech ($13M) on 2024-01-02 and Zeabuz ($2M) on 2023-02-20, which are outside that 90-day window.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.